Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second Dose of Tranexamic Acid in Trauma Patients
NCT03846973Phase 3Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic hemorrhage comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Death in hospital at 4 weeks. Started Dec 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT03846973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03846973.